The largest database of trusted experimental protocols
> Living Beings > Bacterium > Proteus vulgaris

Proteus vulgaris

Proteus vulgaris is a Gram-negative, rod-shaped bacterium commonly found in the human gastrointestinal tract and in the environment.
It is an opportunistic pathogen that can cause a variety of infections, including urinary tract infections, wound infections, and bacteremia.
Proteus vulgaris is known for its ability to swarm and produce a characteristic swarming motility on agar surfaces.
It is also capable of producing a variety of virulence factors that contribute to its pathogenicity.
Researchers studying Proteus vulgaris can utilize the PubCompare.ai platform to find reliable protocols, compare methods side-by-side, and optimize their experiments for reproducibility and accuracy.
This AI-powered tool can help researchers discover the best protocols and products for their Proteus vulgaris research, all in one convenient location.

Most cited protocols related to «Proteus vulgaris»

The HiSeq and MiSeq metagenomes were built using 20 sets of bacterial whole-genome shotgun reads. These reads were found either as part of the GAGE-B project [21 (link)] or in the NCBI Sequence Read Archive. Each metagenome contains sequences from ten genomes (Additional file 1: Table S1). For both the 10,000 and 10 million read samples of each of these metagenomes, 10% of their sequences were selected from each of the ten component genome data sets (i.e., each genome had equal sequence abundance). All sequences were trimmed to remove low quality bases and adapter sequences.
The composition of these two metagenomes poses certain challenges to our classifiers. For example, Pelosinus fermentans, found in our HiSeq metagenome, cannot be correctly identified at the genus level by Kraken (or any of the other previously described classifiers), because there are no Pelosinus genomes in the RefSeq complete genomes database; however, there are seven such genomes in Kraken-GB’s database, including six strains of P. fermentans. Similarly, in our MiSeq metagenome, Proteus vulgaris is often classified incorrectly at the genus level because the only Proteus genome in Kraken’s database is a single Proteus mirabilis genome. Five more Proteus genomes are present in Kraken-GB’s database, allowing Kraken-GB to classify reads better from that genus. In addition, the MiSeq metagenome contains five genomes from the Enterobacteriaceae family (Citrobacter, Enterobacter, Klebsiella, Proteus and Salmonella). The high sequence similarity between the genera in this family can make distinguishing between genera difficult for any classifier.
The simBA-5 metagenome was created by simulating reads from the set of complete bacterial and archaeal genomes in RefSeq. Replicons from those genomes were used if they were associated with a taxon that had an entry associated with the genus rank, resulting in a set of replicons from 607 genera. We then used the Mason read simulator [22 ] with its Illumina model to produce 10 million 100-bp reads from these genomes. First we created simulated genomes for each species, using a SNP rate of 0.1% and an indel rate of 0.1% (both default parameters), from which we generated the reads. For the simulated reads, we multiplied the default mismatch and indel rates by five, resulting in an average mismatch rate of 2% (ranging from 1% at the beginning of reads to 6% at the ends) and an indel rate of 1% (0.5% insertion probability and 0.5% deletion probability). For the simBA-5 metagenome, the 10,000 read set was generated from a random sample of the 10 million read set.
Full text: Click here
Publication 2014
Bacteria Citrobacter Deletion Mutation Enterobacter Enterobacteriaceae Genome Genome, Archaeal Genome, Bacterial Genome Components INDEL Mutation Klebsiella Metagenome Pelosinus fermentans Proteus Proteus mirabilis Proteus vulgaris Replicon Salmonella Strains
The sequence of the gene for Proteus vulgaris chondroitinase ABC was reported by Ryan et al. (1994) (Entrez accession number AAB43331 = gi1828877) and confirmed by Prabhakar et al. (2005a) (link). The encoded sequence was also confirmed from the protein crystal structure by Huang et al. (2003) (link). These studies showed that an independent sequence reported by Sato et al. (1994) (link) contained several errors.
We obtained a cDNA for P. vulgaris chondroitinase ABC in a prokaryotic expression vector, although the coding region lacked an N-terminal signal sequence to direct secretion from cells, and had two inactivating mutations. Apart from these changes, the clone encoded the same sequence reported by Ryan et al. (1994) . We corrected the two mutations by site-directed mutagenesis, and added a eukaryotic signal sequence from mouse matrix metalloprotease 2 (GenBank accession no. NM008610 = gi47271505) (Reponen et al., 1992 (link)). An optimised Kozak sequence was also inserted at the 5′ end to allow recognition by eukaryotic ribosomes and to maximise protein yield. We further changed some of the codons that are unfavourable for translation by mammalian ribosomes, replacing them with those used more frequently by mammalian cells. The resulting ‘initial sequence’ is shown in Supplementary Fig. S1.
This modified cDNA was subcloned into the eukaryotic expression vector pcDNA 3.1 (Invitrogen), in which transcription is directed by the cytomegalovirus promoter, which directs high-level expression in a wide range of mammalian cells. This initial clone is named C4.
Protein structure was visualised using RasMol Molecular Graphics Visualisation Tool (by Roger Sayle: http://www.rasmol.org).
Full text: Click here
Publication 2010
Cells Chondroitin ABC Lyase Clone Cells Cloning Vectors Codon Cytomegalovirus DNA, Complementary Eukaryotic Cells Genes Loss of Function Mutation Mammals MMP2 protein, human Mus Mutagenesis, Site-Directed Mutation Prokaryotic Cells Proteins Proteus vulgaris Ribosomes secretion Signal Peptides Transcription, Genetic
Chondroitin sulfate A (CS-A) and dermatan sulfate (DS) oligosaccharides were independently prepared by partial enzymatic depolymerization of bovine trachea chondroitin sulfate A (Celsus Laboratories, Cincinnati, OH, USA) and porcine intestinal mucosa dermatan sulfate (Celsus Laboratories). A 20 mg/mL solution of each, in 50 mM Tris-HCl/60 mM sodium acetate buffer, pH 8 was incubated at 37 °C with chondroitin ABC lyase from Proteus vulgaris, EC 4.2.2.4. (Associates of Cape Cod Inc., East Falmouth, MA, USA). After the absorbance at 232 nm indicated the digestion was 50 % completed, the digestion mixture was heated at 100 °C for 3 min. The resulting oligosaccharide mixture was filtered by a 0.22 μm unit (Millipore, Billerica, MA, USA) and fractionated by low pressure GPC on a Bio-Gel P10 (Bio-Rad, Richmond, CA, USA) column. Fractions containing oligosaccharides of interest were desalted by GPC on a Bio-Gel P2 column and freeze-dried [48 (link)]. Further purification of compounds was carried out using strong anion exchange high-pressure liquid chromatography (SAX-HPLC) on a semi-preparative SAX S5 Spherisorb column (Waters Corp, Milford, MA, USA). The SAX-HPLC fractions containing >90 % of oligosaccharides were collected, desalted by GPC, and freeze-dried. The solid was reconstituted in water and purified a second time by SAX-HPLC. Only the top 30 % of the chromatographic peak was collected, desalted, and freeze-dried. Concentration of the oligosaccharide solutions was determined by measuring the absorbance at 232 nm (e=3800M−1 cm−1). The resulting fractions containing individual oligosaccharides were characterized by PAGE, ESI-MS, and high-field nuclear magnetic resonance (NMR) spectroscopy [49 (link)].
Publication 2012
Anions Cattle Chondroitin 4-Sulfate Chondroitin ABC Lyase Chromatography Dermatan Sulfate Digestion Enzymes Freezing High-Performance Liquid Chromatographies Intestinal Mucosa Oligosaccharides Pigs Pressure Proteus vulgaris Sodium Acetate Spectroscopy, Nuclear Magnetic Resonance Trachea Tromethamine
A defined microbial community was prepared in order to compare Illumina library sequencing to traditional Sanger sequencing. To prepare this community, genomic DNA from the following 12 bacterial strains was added in equivalent amounts with the exception of Staphylococcus, for which threefold more DNA was added: Pseudomonas aeruginosa (ATCC 10145), Escherichia coli (ATCC 11303), Klebsiella pneumoniae (Macdonald Campus of McGill culture collection), Alicaligenes faecalis (ATCC 8750), Enterobacter aerogenes (ATCC 13048), Lactobacillus plantarum (ATCC 8014), Bacillus subtilis (ATCC 6633), Enterococcus faecalis (ATCC 19433), Citrobacter freundii (ATCC 8090), Proteus vulgaris (ATCC 6380), Clostridia sporogenes (ATCC 19404), Staphylococcus epidermidis (ATCC 12228). The V3 region of the 16S rRNA gene was amplified as described above, in duplicate using two different barcodes, in order to evaluate library reproducibility. These additional two libraries were sequenced as part of a separate Illumina run containing additional environmental samples. Near full-length 16S rRNA genes from the same pool of DNA were amplified using 27F/1492R primers as described above and inserted into the TOPO cloning system (Invitrogen, Canada) then used to transform E. coli, as per kit instructions. Ninety-six positive clones were chosen and sequenced with conventional Sanger sequencing. All sequences were classified using the RDP classifier with the same conditions as below.
Publication 2011
Bacillus subtilis Citrobacter freundii Clone Cells Clostridium sporogenes DNA, Bacterial DNA Library Enterobacter aerogenes Enterococcus faecalis Escherichia coli Genome Klebsiella pneumoniae Lactobacillus plantarum Microbial Community Oligonucleotide Primers Proteus vulgaris Pseudomonas aeruginosa Ribosomal RNA Genes Staphylococcus Staphylococcus epidermidis Strains Topotecan
U343, U87, U87ΔEGFR, LN229, Gli36 EGFR-H2B-RFP, X12 human glioma cells and Vero cells were maintained as described (20 (link)–22 (link)). Mouse monoclonal anti-chondroitin-4-sulfate antibody (clone BE-123, MP Biomedicals Inc, Aurora, OH) was used to probe for Chase functionality. Tumor bearing sections were labeled with Wisteria floribunda lectin (WFL, Vector Labs Inc., Burlingame, CA), anti vimentin (clone SP20, Lab Vision, Fremont, CA). Oncolytic viruses rHsvQ, rHsvQLuc and rQNestin34.5 have been previously described (23 (link)–24 (link)). Genomic DNA from Proteus vulgaris (ATCC number 9920D) was used as template to clone Chase-ABC-I cDNA as described (25 (link)). The PCR product was sub-cloned into pSecTag/FRT/V5 His-Topo vector (Invitrogen, Carlsbad, CA) and used to generate OV-Chase as previously described (24 (link)). Cytotoxicity of viruses was assessed by a standard crystal violet assay (26 (link)).
Publication 2010
Antibodies, Anti-Idiotypic Biological Assay Cells Chondroitin 4-Sulfate Cloning Vectors Cytotoxin DNA, Complementary EGFR protein, human Genome Glioma Homo sapiens Mus Neoplasms Oncolytic Viruses Proteus vulgaris Topotecan Vero Cells Vimentin Violet, Gentian Virus Vision Wisteria floribunda lectin

Most recents protocols related to «Proteus vulgaris»

The antimicrobial activity of phycobiliprotein extract from Arthrospira fusiformis was tested against thirteen microbial strains. Previously identified methicillin-resistantStaphylococcus aureus (MRSA) clinical isolate obtained from the blood of a patient at Almery University Hospital (Alexandria, Egypt) was used in this study [46 (link)]. Candida albicans ATCC 10231 and Staphylococcus aureus ATCC 25923 strains were obtained from Becton Dickinson (France). Salmonella typhi ATCC 19430, Escherichia coli ATCC 25922, Salmonella typhimurium LT2, and Shigella sonnei ATCC 25931 were purchased from an American-type culture collection (ATCC, USA). Aspergillus niger, Aspergillus flavus, Klebsiella pneumonia, Pseudomonas aeruginosa, Serratia marcescens, and Proteus vulgaris were collected from Mycology Center of Al-Azhar University (Cairo, Egypt), and Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Assiut Branch (Egypt). A culture aliquot (100 μl) of each strain of bacteria was added to Luria Bertani (LB) broth, incubated overnight at 37°C, and then stored in 20% glycerol at −80°C to be used as seeds stock [47 (link)]. Stock cultures of C. albicans, A. niger, and A. flavus were maintained on potato dextrose agar (PDA) overnight at 30°C for C. albicans and at 25°C for 5 days for A. niger and A. flavus [47 (link)]. To evaluate antibacterial activity, cation-adjusted Mueller–Hinton (CAMH) broth and Mueller–Hinton agar were used, while antifungal activity was evaluated using potato dextrose broth and potato dextrose agar.
Full text: Click here
Publication 2023
Agar Anti-Bacterial Agents Antifungal Agents Aspergillus flavus Aspergillus niger Bacteria Blood Candida albicans Escherichia coli Faculty Glucose Glycerin Klebsiella Limnospira fusiformis Methicillin Microbicides Patients Phycobiliproteins Plant Embryos Pneumonia Proteus vulgaris Pseudomonas aeruginosa Salmonella typhi Salmonella typhimurium LT2 Serratia marcescens Shigella sonnei Solanum tuberosum Staphylococcus aureus Infection Strains
Flow cytometry was carried out according to standard methods as described in [19 (link)] using an Attune NxT flow cytometer (ThermoFisher Scientific). Cells were detached with non-enzymatic cell dissociation solution (Merck) or briefly (for Itgb4 staining only) trypsinised with 0.04% trypsin/ 0.03% EDTA (PromoCell). For surface GAG detection, cells were treated with 1mU of heparinase III (EC4.2.2.8 from Flavobacterium heparinum) to expose neo-epitope of heparan sulphate or with chondroitinase ABC (EC 4.2.2.4 from Proteus vulgaris) (AMS Biotechnology) for 1h at 37°C prior to the staining procedures. Antibodies were Δ-HS (F69-3G10, AMS Biotechnology), CS (CS56, Merck), perlecan (7B5, ThermoFisher Scientific), glypican-1 (AF4519), integrin β4/ CD104 (clone 439-9B, eBioscience), integrin β1/ CD29 (P4C10, NBP2-36561), syndecan-2 (MAB2965), biglycan (AF2667), laminin α5 (NBP2-42391) from Biotechne. Isotype control mouse IgG1 (P3.6.2.8.1; 14-4714-81 from Invitrogen), mouse IgG2b (MG2B00), goat IgG (AB-108-C from R&D), rat IgG2b (14-4031-81), mouse IgM (PFR-03) and fluorophore-conjugated secondary antibodies goat anti-mouse IgG PE (12-4010-82), donkey anti-goat IgG FITC (A16000) and anti-rat IgG FITC (31629) were from ThermoFisher Scientific. The main population was gated by forward and side scatter plot of untreated cells using FlowJo (v9); among this, single cell population of 104 cells per condition was subjected to analysis. Mean fluorescence intensity was determined and presented as % relative to untreated control.
Full text: Click here
Publication Preprint 2023
anti-IgG Antibodies Biglycan Cells Chondroitin ABC Lyase Clone Cells Edetic Acid Enzymes Epitopes Equus asinus Flow Cytometry Fluorescein-5-isothiocyanate Fluorescence Glypican-1 Goat heparinase III IgG1 IgG2B Immunoglobulin Isotypes Integrins ITGB4 protein, human Laminin Mus Pedobacter heparinus perlecan Proteus vulgaris Sulfate, Heparan Syndecan-2 Trypsin
In this assay, two bacteria that needed the lowest concentrations of C. brownei essential oil to inhibit bacterial growth were selected; in this case: Listeria grayi ATCC 1912 (Gram-positive bacteria) and Proteus vulgaris ATCC 6380 (Gram-negative bacteria). The components of the essential oil were separated on a Merk silica gel HPTLC chromatographic plate; essential oil at a concentration of 30 mg/mL was incubated using a mobile phase composed of toluene, ethyl acetate and petroleum ether in proportions of 97:7:20. Disclosure was performed by covering the plate with culture medium, containing the target bacteria and the TTC dye. The plates were incubated for 24 h at 37 degrees Celsius, showing activity in those fractions that stain white [21 (link)]. Subsequently, the active fractions were extracted with dichloromethane and analyzed in a GC/MS, under the same conditions described in Section 4.4 for TR-5MS column.
Full text: Click here
Publication 2023
Bacteria Biological Assay Cardiac Arrest Culture Media ethyl acetate Gas Chromatography-Mass Spectrometry Gel Chromatography Gram-Positive Bacteria Gram Negative Bacteria Listeria grayi Methylene Chloride naphtha Oils, Volatile Proteus vulgaris Silicon Dioxide Stains Toluene
Antimicrobial activity was determined with the diffusion method in a solid nutrient media of agar. Mueller–Hinton Agar (Mueller–Hinton II Agar, BBL, Cockeysville, MD, USA) was used.
Standard cultures of nonspore bacteria (all bacteria were obtained from American Type Culture Collection (ATCC))—Staphylococcus aureus (ATCC 25923; human nasal microbiota), Staphylococcus epidermidis (ATCC 12228; human skin microbiota), Enterococcus faecalis (ATCC 29212; human colonic microbiota), Escherichia coli (ATCC 25922; human colonic microbiota), Klebsiella pneumoniae (ATCC 13883; human microbiota), Pseudomonas aeruginosa (ATCC 27853; human microbiota), and Proteus vulgaris (ATCC8427; human microbiota). Bacteria were grown for 20–24 h at 35–37 °C on Mueller–Hinton Agar. The bacterial suspension was prepared from cultures of cultivated bacteria in sterile physiological sodium chloride (0.9%) solution, standardised with a McFarland standard indicator. The bacterial suspension was considered standardised when the indicator value was 0.5 (1 mL of bacterial suspension contains 1.5 × 108 cells of the micro-organism).
Standard spore bacteria cultures of Bacillus cereus (ATCC 6633; soil microbiota) were grown for 7 days at 35–37 °C on Mueller–Hinton Agar. After growing the culture of spore bacteria, it was washed off the surface of the medium with a sterile physiologic solution. The prepared suspension was heated for 30 min at 70 °C and diluted with physiological saline until the spore concentration in 1 mL was between 10 × 106 and 100 × 106.
The standard culture of the fungus Candida albicans (ATCC 10231; human microbiota) was grown for 20 to 24 h at 30 °C for 72 h on Sabouraud agar. The fungal suspension was prepared from cultivated fungal cultures in physiological saline and standardised with a McFarland standard indicator.
A 0.5 McFarland turbidity suspension of the standard bacteria was prepared. The bottom of the Petri dishes was divided into 9 segments. The technology of reference microorganisms to Mueller–Hinton agar was used to determine the antimicrobial activity of Glycyrrhiza glabra L. and Trifolium pratense L. extracts. The disk method was used to determine the antimicrobial activity of Myristica fragrans Houtt. essential oil.
Full text: Click here
Publication 2023
Agar Bacillus cereus Bacteria Candida Cells Colon Diffusion Enterococcus faecalis Escherichia coli Glycyrrhiza glabra extract Homo sapiens Hyperostosis, Diffuse Idiopathic Skeletal Klebsiella pneumoniae Microbial Community Microbicides Myristica fragrans Nose Nutrients Oils, Volatile physiology Proteus vulgaris Pseudomonas aeruginosa Saline Solution Skin Sodium Chloride Spores Spores, Bacterial Staphylococcus aureus Staphylococcus epidermidis Sterility, Reproductive Trifolium pratense
Bovine aortic endothelial cells and smooth muscle cells were purchased from Cell Applications (San Diego, CA, USA). Dulbecco’s modified Eagle’s medium (DMEM) and Ca2+- and Mg2+-free phosphate-buffered saline (CMF-PBS) were obtained from Nissui Pharmaceutical (Tokyo, Japan). Fetal bovine serum (FBS) was purchased from Biosera (Kansas City, MO, USA). PMTAS, DBMA, and SbPh3 were synthesized as reported previously [7 (link)] and diluted in dimethyl sulfoxide for experimental use. [35S]Na2SO4, Tran35S-label metabolic labeling reagent, and [methyl-3H]thymidine were obtained from MP Biomedicals (Santa Ana, CA, USA). L-[14C(U)]-Leucine was purchased from Moravek Biochemicals (Brea, CA, USA). Sepharose CL-4B, Sepharose CL-6B, and PD-10 columns were procured from GE Healthcare (Buckinghamshire, UK). Protease-free chondroitin ABC lyase (EC 4.2.2.4, derived from Proteus vulgaris), heparinase II (derived from Flavobacterium heparinum), and heparinase III (EC 4.2.2.8; derived from Flavobacterium heparinum) were purchased from Seikagaku (Tokyo, Japan). SbCl3, SbCl5, diethylaminoethyl-Sephacel (DEAE-Sephacel), Kodak XAR-2 film, and Immobbillon-P membranes were purchased from Merck KGaA (Darmstadt, Germany). Anti-perlecan antibody (sc-25848) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Horseradish peroxidase-conjugated anti-rabbit IgG (#7074) was obtained from Cell Signaling Technology (Beverly, MA, USA). The Chloride Assay Kit and Immunostar basic kit were obtained from Fujifilm Wako Pure Chemical Industries (Osaka, Japan). QIAzol lysis reagent was purchased from QIAGEN (Valencia, CA, USA). Luna Universal qPCR Master Mix was obtained from New England Biolabs Inc. (Ipswich, MA, USA). A high-capacity cDNA reverse transcription kit was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Other reagents of the highest grade available were obtained from Nacalai Tesque (Kyoto, Japan).
Full text: Click here
Publication 2023
anti-IgG Antibodies, Anti-Idiotypic Aorta Biological Assay Bos taurus Cells Chlorides Chondroitin ABC Lyase DNA, Complementary Eagle Endothelial Cells Fetal Bovine Serum heparinase II heparinase III Horseradish Peroxidase Leucine Myocytes, Smooth Muscle Pedobacter heparinus Peptide Hydrolases perlecan Pharmaceutical Preparations Phosphates Proteus vulgaris Rabbits Reverse Transcription Saline Solution Sepharose CL 4B sepharose CL 6B Sulfoxide, Dimethyl Thymidine Tissue, Membrane

Top products related to «Proteus vulgaris»

Sourced in United States, China, Germany, United Kingdom, France, Portugal, Canada, Brazil, Italy
Escherichia coli is a bacterium that is commonly used in laboratory settings. It serves as a model organism for microbiology and molecular biology research. Escherichia coli can be cultivated and studied to understand fundamental cellular processes and mechanisms.
Sourced in United States, Brazil, China, Germany, Australia, United Kingdom, Italy, Malaysia
Pseudomonas aeruginosa is a bacterial strain available from the American Type Culture Collection (ATCC). It is a Gram-negative, aerobic bacterium commonly found in soil and water environments. This strain can be used for various research and testing purposes.
Sourced in United States, China, United Kingdom, Germany, Brazil, Malaysia, Italy, Portugal
Staphylococcus aureus is a bacterial strain available in the American Type Culture Collection (ATCC) product portfolio. It is a Gram-positive, spherical-shaped bacterium commonly found in the human nasal passages and on the skin. This strain is widely used in research and laboratory settings for various applications.
Sourced in United States
Proteus vulgaris is a bacterium that can be used for laboratory applications. It is a Gram-negative, rod-shaped, and motile microorganism.
Sourced in United States
Chondroitinase ABC is an enzyme isolated from the bacterium Proteus vulgaris. It functions to cleave chondroitin sulfate, a glycosaminoglycan found in the extracellular matrix of various tissues. This enzyme is used in research applications to study the role of chondroitin sulfate in biological processes.
Sourced in United States, China, Germany
Klebsiella pneumoniae is a Gram-negative, non-spore-forming, encapsulated, lactose-fermenting, facultatively anaerobic, rod-shaped bacterium. It is a common inhabitant of the human gastrointestinal tract and can cause various types of infections, including pneumonia, urinary tract infections, and septicemia.
Sourced in United States, United Kingdom, China
Staphylococcus epidermidis is a type of bacteria commonly found on the human skin and mucous membranes. It is a Gram-positive, coagulase-negative, and non-spore-forming coccus. Staphylococcus epidermidis is a prevalent microorganism and is often used in research and laboratory settings for various applications.
Sourced in United States, Australia, Germany, Italy, France
Candida albicans is a species of yeast that is commonly found in the human microbiome. It is a versatile and well-studied organism used in a variety of laboratory applications, including microbiology, immunology, and biochemistry research.
Sourced in United States, China, Brazil
Bacillus subtilis is a Gram-positive, rod-shaped bacterium commonly found in soil and the gastrointestinal tract of humans and animals. It is a widely used laboratory strain for research and industrial applications.
Sourced in United States, Portugal, China
Bacillus cereus is a Gram-positive, spore-forming bacterium that is commonly found in the environment. It is a type of microorganism that can be used in various laboratory applications.

More about "Proteus vulgaris"

Proteus vulgaris is a Gram-negative, rod-shaped bacterium that is commonly found in the human gastrointestinal tract and in the environment.
As an opportunistic pathogen, it can cause a variety of infections, including urinary tract infections, wound infections, and bacteremia.
Proteus vulgaris is known for its characteristic swarming motility on agar surfaces, which is enabled by its ability to produce a variety of virulence factors.
Researchers studying Proteus vulgaris can utilize the PubCompare.ai platform to find reliable protocols, compare methods side-by-side, and optimize their experiments for reproducibility and accuracy.
This AI-powered tool can help researchers discover the best protocols and products for their Proteus vulgaris research, all in one convenient location.
Proteus vulgaris is often compared to other clinically relevant bacteria, such as Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus, which are also known for their pathogenicity and ability to cause various infections.
Additionally, Proteus vulgaris is known to produce an enzyme called Chondroitinase ABC, which has potential applications in tissue engineering and regenerative medicine.
Other related bacteria, such as Klebsiella pneumoniae, Staphylococcus epidermidis, Candida albicans, Bacillus subtilis, and Bacillus cereus, may also be of interest to researchers studying Proteus vulgaris, as they share some similarities in terms of their habitats, virulence factors, and potential for causing infections.
By utilizing the insights and tools provided by PubCompare.ai, researchers can optimize their Proteus vulgaris experiments and contribute to a better understanding of this opportunistic pathogen, ultimately leading to improved prevention and treatment strategies.